Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer.

Cherkasova E, Scrivani C, Doh S, Weisman Q, Takahashi Y, Harashima N, Yokoyama H, Srinivasan R, Linehan WM, Lerman MI, Childs RW.

Cancer Res. 2016 Apr 15;76(8):2177-85. doi: 10.1158/0008-5472.CAN-15-3139. Epub 2016 Feb 9.

2.

Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers.

Loginov VI, Dmitriev AA, Senchenko VN, Pronina IV, Khodyrev DS, Kudryavtseva AV, Krasnov GS, Gerashchenko GV, Chashchina LI, Kazubskaya TP, Kondratieva TT, Lerman MI, Angeloni D, Braga EA, Kashuba VI.

PLoS One. 2015 May 11;10(5):e0123369. doi: 10.1371/journal.pone.0123369. eCollection 2015.

3.

Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.

Senchenko VN, Kisseljova NP, Ivanova TA, Dmitriev AA, Krasnov GS, Kudryavtseva AV, Panasenko GV, Tsitrin EB, Lerman MI, Kisseljov FL, Kashuba VI, Zabarovsky ER.

Epigenetics. 2013 Apr;8(4):409-20. doi: 10.4161/epi.24233. Epub 2013 Mar 11.

4.

NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.

Kashuba V, Dmitriev AA, Krasnov GS, Pavlova T, Ignatjev I, Gordiyuk VV, Gerashchenko AV, Braga EA, Yenamandra SP, Lerman M, Senchenko VN, Zabarovsky E.

Int J Mol Sci. 2012 Oct 18;13(10):13352-77. doi: 10.3390/ijms131013352.

5.

Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.

Dmitriev AA, Kashuba VI, Haraldson K, Senchenko VN, Pavlova TV, Kudryavtseva AV, Anedchenko EA, Krasnov GS, Pronina IV, Loginov VI, Kondratieva TT, Kazubskaya TP, Braga EA, Yenamandra SP, Ignatjev I, Ernberg I, Klein G, Lerman MI, Zabarovsky ER.

Epigenetics. 2012 May;7(5):502-13. doi: 10.4161/epi.19801. Epub 2012 May 1.

PMID:
22491060
6.

LRRC3B gene is frequently epigenetically inactivated in several epithelial malignancies and inhibits cell growth and replication.

Haraldson K, Kashuba VI, Dmitriev AA, Senchenko VN, Kudryavtseva AV, Pavlova TV, Braga EA, Pronina IV, Kondratov AG, Rynditch AV, Lerman MI, Zabarovsky ER.

Biochimie. 2012 May;94(5):1151-7. doi: 10.1016/j.biochi.2012.01.019. Epub 2012 Feb 2.

PMID:
22321817
7.

Differential expression of CHL1 gene during development of major human cancers.

Senchenko VN, Krasnov GS, Dmitriev AA, Kudryavtseva AV, Anedchenko EA, Braga EA, Pronina IV, Kondratieva TT, Ivanov SV, Zabarovsky ER, Lerman MI.

PLoS One. 2011 Mar 7;6(3):e15612. doi: 10.1371/journal.pone.0015612.

8.

Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.

Senchenko VN, Anedchenko EA, Kondratieva TT, Krasnov GS, Dmitriev AA, Zabarovska VI, Pavlova TV, Kashuba VI, Lerman MI, Zabarovsky ER.

BMC Cancer. 2010 Mar 1;10:75. doi: 10.1186/1471-2407-10-75.

9.

High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer.

Kashuba VI, Pavlova TV, Grigorieva EV, Kutsenko A, Yenamandra SP, Li J, Wang F, Protopopov AI, Zabarovska VI, Senchenko V, Haraldson K, Eshchenko T, Kobliakova J, Vorontsova O, Kuzmin I, Braga E, Blinov VM, Kisselev LL, Zeng YX, Ernberg I, Lerman MI, Klein G, Zabarovsky ER.

PLoS One. 2009 May 29;4(5):e5231. doi: 10.1371/journal.pone.0005231.

10.

Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?

Kaluz S, Kaluzov√° M, Liao SY, Lerman M, Stanbridge EJ.

Biochim Biophys Acta. 2009 Apr;1795(2):162-72. doi: 10.1016/j.bbcan.2009.01.001. Epub 2009 Jan 22. Review.

11.

Expression of transmembrane carbonic anhydrases, CAIX and CAXII, in human development.

Liao SY, Lerman MI, Stanbridge EJ.

BMC Dev Biol. 2009 Mar 16;9:22. doi: 10.1186/1471-213X-9-22.

12.

HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro.

Wang F, Grigorieva EV, Li J, Senchenko VN, Pavlova TV, Anedchenko EA, Kudryavtseva AV, Tsimanis A, Angeloni D, Lerman MI, Kashuba VI, Klein G, Zabarovsky ER.

PLoS One. 2008 Aug 22;3(8):e3031. doi: 10.1371/journal.pone.0003031.

13.

Two novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors.

Ivanov SV, Ivanova AV, Salnikow K, Timofeeva O, Subramaniam M, Lerman MI.

Biochem Biophys Res Commun. 2008 Jun 13;370(4):536-40. doi: 10.1016/j.bbrc.2008.03.066. Epub 2008 Mar 24.

14.

Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells.

Takahashi Y, Harashima N, Kajigaya S, Yokoyama H, Cherkasova E, McCoy JP, Hanada K, Mena O, Kurlander R, Tawab A, Srinivasan R, Lundqvist A, Malinzak E, Geller N, Lerman MI, Childs RW.

J Clin Invest. 2008 Mar;118(3):1099-109. doi: 10.1172/JCI34409. Erratum in: J Clin Invest. 2008 Apr;118(4):1584. Abdul, Tawab [corrected to Tawab, Abdul].

15.

Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage.

Lo PH, Xie D, Chan KC, Xu FP, Kuzmin I, Lerman MI, Law S, Chua D, Sham J, Lung ML.

Cancer Lett. 2007 Nov 18;257(2):199-205. Epub 2007 Aug 27.

PMID:
17720308
16.

Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma.

Yau WL, Lung HL, Zabarovsky ER, Lerman MI, Sham JS, Chua DT, Tsao SW, Stanbridge EJ, Lung ML.

Int J Cancer. 2006 Dec 15;119(12):2821-6.

17.

Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes.

Angeloni D, ter Elst A, Wei MH, van der Veen AY, Braga EA, Klimov EA, Timmer T, Korobeinikova L, Lerman MI, Buys CH.

Genes Chromosomes Cancer. 2006 Jul;45(7):676-91.

PMID:
16607615
18.
19.

Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas.

Yi Lo PH, Chung Leung AC, Xiong W, Law S, Duh FM, Lerman MI, Stanbridge EJ, Lung ML.

Cancer Lett. 2006 Mar 28;234(2):184-92.

PMID:
15885884
20.

Transcriptional regulator CTCF controls human interleukin 1 receptor-associated kinase 2 promoter.

Kuzmin I, Geil L, Gibson L, Cavinato T, Loukinov D, Lobanenkov V, Lerman MI.

J Mol Biol. 2005 Feb 18;346(2):411-22. Epub 2004 Dec 22.

PMID:
15670593

Supplemental Content

Loading ...
Support Center